A study to determine the incidence of infection and course of antibody levels along with antibody response to vaccination and factors associated with immunogenicity in an emergency department healthcare worker cohort
Latest Information Update: 25 Feb 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 25 Feb 2022 New trial record
- 02 Feb 2022 Results published in the American Journal of Emergency Medicine